The extra general meeting of Acarix AB was held today on 9 June 2023 and the following resolutions were passed by the meeting.
Resolution to approve the board of directors resolution to issue new. | June 9, 2023
In December 2022, Acarix AB carried out a rights issue of shares and warrants of series 2022:U . The exercise period for the warrants ran from and including May 2, 2023 up to and including May 16,. | May 22, 2023
The shareholders of Acarix AB, reg. no. 559009-0667, are hereby convened to the annual general meeting to be held on Thursday 11 May 2023 at 10.00 AM at the Baker & McKenzie Advokatbyrå s. | April 11, 2023
Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announced a strategic sales partnership with CompleMed, LLC, a national sales organization
With effect from December 16, 2022, the unit rights in Acarix AB will be traded
on First North Premier Growth Market. Trading will continue up until and
including December 27, 2022. Instrument: Unit